Latest Alcohols Stories

Cobalt Technologies Adds Bunge as Strategic Investor

2012-10-30 11:22:41

MOUNTAIN VIEW, Calif., Oct. 30, 2012 /PRNewswire/ -- Cobalt Technologies ("Cobalt"), a leading developer of next generation bio-based chemicals, today announced that Bunge Global Innovation LLC, a wholly-owned subsidiary of global agribusiness and food company Bunge Limited (NYSE: BG) ("Bunge"), has joined its Series E Preferred Stock round as a strategic investor. The investment follows Cobalt's agreement with Bunge and specialty chemicals company Rhodia Poliamida e Especialidades...

Par Pharmaceutical Acquires Rights to Market and Distribute Generic Seroquel XR® in the U.S.

2012-10-29 07:25:59

WOODCLIFF LAKE, N.J., Oct. 29, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive acquisition and license agreement with Handa Pharmaceuticals, LLC to acquire Handa's Abbreviated New Drug Application (ANDA) for quetiapine fumarate extended-release tablets, the generic version of AstraZeneca's Seroquel XR(®). Handa believes it is the first applicant to file an ANDA containing...

Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe

2012-10-25 03:21:18

TOKYO, October 25, 2012 /PRNewswire/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) confirms the information released today by Novartis that QVA149, (indacaterol maleate / glycopyrronium bromide) an investigational drug for chronic obstructive pulmonary disease (COPD) has been filed for marketing authorisation with the European Medicines Agency (EMA), triggering a $5 million milestone payment to Sosei. The first five studies in the Phase III IGNITE...

d'Oliveira & Associates Now Offers a No Win, No Fee Promise To Those Injured by the Anti-Depressant Drug Pristiq

2012-10-25 04:03:30

The law firm of d'Oliveira & Associates is working with some of the leading Pristiq lawyers in the country handling Pristiq cases and wants the public to know they offer a No Win No Fee Promise for Pristiq users who have developed serious liver or heart problems or allergic reactions. This means that you or your family would pay no legal fees until you receive a settlement or award of you Pristiq claim or Pristiq lawsuit. (PRWEB) October 24, 2012 Reuters recently reported that a...

The Vitamin Shoppe Now Offering a Youth Infusion® To Its Customers

2012-10-24 07:31:01

CROFTON, Md., Oct. 24, 2012 /PRNewswire/ -- The Vitamin Shoppe is bringing Youth Infusion® (www.drinkyouthinfusion.com ) to its customers. The innovative multi-vitamin supplement is the signature product of Infusion Sciences, Inc. "We are thrilled and could not pick a better healthy living partner to carry Youth Infusion® than The Vitamin Shoppe, a retailer known for bringing its customers cutting edge health products," says Infusion Sciences Founder and Youth Infusion®...

The Deficiency Of A Single B Vitamin Can Lead To Poor Health As Reported In A Recent Paper Published By Riordan Clinic Researchers

2012-10-24 07:28:14

WICHITA, Kan., Oct. 24, 2012 /PRNewswire-USNewswire/ -- Researchers Mikirova N, Taylor P, Feldcamp C. and Casciari J under the supervision of Hugh D. Riordan, M.D., at the Riordan Clinic in Wichita, Kansas, published "The Effects of a Primary Nutritional Deficiency (Vitamin B Study)" in Food and Nutrition Sciences, 2012, 3, 1238-1244 (http://www.scirp.org/journal/PaperInformation.aspx?paperID=22300). Rats were deprived of a single B vitamin to determine the side effects of such...

Pediatric Intensive Care Patients Prescribed Off-Label Medications

2012-10-22 22:15:37

"Off label" drugs are medications that have not been tested for safety or efficacy for a specific patient age or condition. New research presented Oct. 21 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in New Orleans found that off-label treatments were ordered for 96 percent of all pediatric patients, and 100 percent of patients ages 13-17, in the intensive care unit of an urban children's hospital. In "Off-Label Drug Use in the Pediatric Intensive Care...

Collegium Announces Poster Presentation for Oxycodone DETERx®, a Tamper-Resistant, Extended-Release Opioid at 2012 American Association of Pharmaceutical Scientists Annual Meeting

2012-10-19 07:23:21

CUMBERLAND, R.I., Oct. 19, 2012 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the presentation of a scientific poster titled "Alternate methods of oral administration for Oxycodone DETERx, a novel, extended-release, tamper-resistant opioid formulation" at the 2012 Annual Meeting of the American Association of Pharmaceutical Scientists, held in Chicago, Illinois...

Avion Pharmaceuticals, LLC, featured on Lifetime® Television Network's The Balancing Act®

2012-10-18 15:22:29

ATLANTA, Oct. 18, 2012 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced its partnership with The Balancing Act®, a daily morning talk show on the Lifetime® Television Network devoted to supporting women. At 7 a.m. EDT on Oct. 29, 2012, The Balancing Act® will air a segment on the importance of proper nutrition during pregnancy and will feature information about the innovative new prenatal vitamin, the Prenate Mini(TM). Prenate Mini...

BioDelivery Sciences Reaffirms its Strengthened Position Following Reexamination of MonoSol Patents

2012-10-18 07:25:05

RALEIGH, N.C., Oct. 18, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) today reaffirmed its continued strong position and ongoing progress made in its defense of a process patent infringement lawsuit previously served against BDSI and its partners for ONSOLIS, by MonoSolRx, LLC (MonoSol). BDSI reaffirms that its products and technologies do not infringe on MonoSol's original patents, and BDSI believes that its position in this matter has only been...